ArticleEuropean journal of pharmacology2014

Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Nidhi Kaushal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.